Skip to Main Content
Mental Health & Behavioral Research

Transcranial Magnetic Stimulation (TMS) for Depression in Autism

What is the purpose of this trial?

This study will evaluate the effects of Transcranial Magnetic Stimulation (TMS), a type of noninvasive brain stimulation for potentially treating depression in autistic individuals. TMS is a therapy that has been approved for conditions like depression, anxious depression, and obsessive-compulsive disorder. Depression is common in autism so there is a need to better understand why autistic individuals have higher rates of depression than neurotypical individuals. In addition, many autistic individuals with depression may not respond to the standard antidepressant medications. In our study we conduct clinical assessments, then EEG and eye tracking experiments before and after TMS.

Participation consists of 2 or 3 visits to our lab and participants will be compensated up to $250.

Contact Information

For more information about this study, including how to volunteer, contact The McPartland Lab

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

  • Last Updated
    04/28/2026
  • Study IRB
    #2000035486